CA2429012A1 — New pharmaceutical compositions based on tiotropium salts and salts of salmeterol
Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2002-05-16 · 24y expired
What this patent protects
The invention relates to novel medicament compositions based on tiotropium salts and on salmeterol salts, to a method for the production thereof, and to their use for treating respiratory tract diseases.
USPTO Abstract
The invention relates to novel medicament compositions based on tiotropium salts and on salmeterol salts, to a method for the production thereof, and to their use for treating respiratory tract diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.